The Progeria Research Foundation
Team
TeamPRF
Niccolo (age 20), Alessandro (age 13) and Sammy (age 28) (pictured above) are among nearly 100 children and young adults with Progeria across the world who are benefitting from the life-extending, FDA-approved lonafarnib drug. PRF will continue to devote funds to ensure access to lonafarnib for all, and to study its long-term effects. But we won’t stop there. PRF is exploring 3 other therapeutic pathways to treat and cure Progeria, attacking this disease: at the Protein, at the RNA and at the DNA levels.
The Progeria Research Foundation is dedicated to making sure all children and young adults with Progeria have a bright future. And thanks to YOU, PRF continues to make a dramatic impact on the length and quality of life for those with Progeria. Please continue your vital support and be ONE who makes the cure POSSIBLE!
Niccolo (age 20), Alessandro (age 13) and Sammy (age 28) (pictured above) are among nearly 100 children and young adults with Progeria across the world who are benefitting from the life-extending, FDA-approved lonafarnib drug. PRF will continue to devote funds to ensure access to lonafarnib for all, and to study its long-term effects. But we won’t stop there. PRF is exploring 3 other therapeutic pathways to treat and cure Progeria, attacking this disease: at the Protein, at the RNA and at the DNA levels.
The Progeria Research Foundation is dedicated to making sure all children and young adults with Progeria have a bright future. And thanks to YOU, PRF continues to make a dramatic impact on the length and quality of life for those with Progeria. Please continue your vital support and be ONE who makes the cure POSSIBLE!
You have no fundraisers at this time.
Be the first person to donate to the cause!
Niccolo (age 20), Alessandro (age 13) and Sammy (age 28) (pictured above) are among nearly 100 children and young adults with Progeria across the world who are benefitting from the life-extending, FDA-approved lonafarnib drug. PRF will continue to devote funds to ensure access to lonafarnib for all, and to study its long-term effects. But we won’t stop there. PRF is exploring 3 other therapeutic pathways to treat and cure Progeria, attacking this disease: at the Protein, at the RNA and at the DNA levels.
The Progeria Research Foundation is dedicated to making sure all children and young adults with Progeria have a bright future. And thanks to YOU, PRF continues to make a dramatic impact on the length and quality of life for those with Progeria. Please continue your vital support and be ONE who makes the cure POSSIBLE!
You have no fundraisers at this time.
Be the first person to donate to the cause!